Open | - |
Close | - |
Volume / Avg. | 0 / 95.392K |
Day Range | - - - |
52 Wk Range | 3.030 - 10.300 |
Market Cap | $158.244M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 2.17% |
Days to Cover | 21.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Achieve Life Sciences (NASDAQ: ACHV) through any online brokerage.
Other companies in Achieve Life Sciences’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Graphite Bio (NASDAQ:GRPH), CytomX Therapeutics (NASDAQ:CTMX) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for Achieve Life Sciences (NASDAQ: ACHV) was reported by Lake Street on Tuesday, March 5, 2024. The analyst firm set a price target for 11.00 expecting ACHV to rise to within 12 months (a possible 138.10% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $4.62 last updated March 15, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Achieve Life Sciences.
Achieve Life Sciences’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Achieve Life Sciences.
Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.